ROR1 and urinary bladder carcinoma: Bayat et al demonstrated that an anti‐ROR1 monoclonal antibody (F1‐B10) induced apoptosis in two human bladder cell lines, and thus proposed that ROR1 may play a role in bladder cancer cell survival.9